Handelsinvest Investeringsforvaltning raised its stake in UnitedHealth Group Inc (NYSE:UNH) by 17.5% in the fourth quarter, HoldingsChannel.com reports. The firm owned 9,413 shares of the healthcare conglomerate’s stock after acquiring an additional 1,400 shares during the period. Handelsinvest Investeringsforvaltning’s holdings in UnitedHealth Group were worth $2,075,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors also recently modified their holdings of UNH. Beach Investment Management LLC. bought a new stake in UnitedHealth Group in the 2nd quarter valued at $556,000. Cedar Capital LLC boosted its holdings in UnitedHealth Group by 18.4% in the 2nd quarter. Cedar Capital LLC now owns 2,786 shares of the healthcare conglomerate’s stock valued at $517,000 after purchasing an additional 433 shares during the period. Sustainable Growth Advisers LP boosted its holdings in UnitedHealth Group by 22.3% in the 2nd quarter. Sustainable Growth Advisers LP now owns 839,366 shares of the healthcare conglomerate’s stock valued at $155,635,000 after purchasing an additional 153,258 shares during the period. Sawtooth Solutions LLC boosted its holdings in UnitedHealth Group by 7.1% in the 2nd quarter. Sawtooth Solutions LLC now owns 3,566 shares of the healthcare conglomerate’s stock valued at $661,000 after purchasing an additional 236 shares during the period. Finally, Alerus Financial NA boosted its holdings in UnitedHealth Group by 1.0% in the 2nd quarter. Alerus Financial NA now owns 27,898 shares of the healthcare conglomerate’s stock valued at $5,172,000 after purchasing an additional 277 shares during the period. 85.87% of the stock is owned by hedge funds and other institutional investors.
UnitedHealth Group Inc (NYSE:UNH) opened at $226.18 on Wednesday. UnitedHealth Group Inc has a 1-year low of $162.74 and a 1-year high of $250.79. The stock has a market cap of $218,870.00, a PE ratio of 23.81, a P/E/G ratio of 1.31 and a beta of 0.74. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.58.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.50 by $0.09. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The firm had revenue of $52.06 billion during the quarter, compared to the consensus estimate of $51.57 billion. During the same period last year, the firm posted $2.11 EPS. The firm’s quarterly revenue was up 9.5% on a year-over-year basis. equities analysts predict that UnitedHealth Group Inc will post 12.51 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 20th. Investors of record on Friday, March 9th will be issued a dividend of $0.75 per share. This represents a $3.00 annualized dividend and a yield of 1.33%. The ex-dividend date is Thursday, March 8th. UnitedHealth Group’s dividend payout ratio is currently 31.58%.
A number of equities analysts have recently commented on the stock. Cantor Fitzgerald reaffirmed a “buy” rating and set a $225.00 price objective on shares of UnitedHealth Group in a report on Monday, November 27th. Wells Fargo & Co reaffirmed an “outperform” rating and set a $245.00 price objective (up from $230.00) on shares of UnitedHealth Group in a report on Wednesday, November 29th. Oppenheimer raised their price objective on shares of UnitedHealth Group from $215.00 to $225.00 and gave the stock an “outperform” rating in a report on Wednesday, November 29th. Credit Suisse Group reaffirmed a “positive” rating and set a $240.00 price objective (up from $233.00) on shares of UnitedHealth Group in a report on Wednesday, November 29th. Finally, Royal Bank of Canada raised their price objective on shares of UnitedHealth Group to $244.00 and gave the stock an “outperform” rating in a report on Wednesday, November 29th. They noted that the move was a valuation call. Two equities research analysts have rated the stock with a hold rating and twenty-six have assigned a buy rating to the company. The company currently has an average rating of “Buy” and an average target price of $243.22.
In other UnitedHealth Group news, CEO Larry C. Renfro sold 22,598 shares of the firm’s stock in a transaction dated Friday, December 15th. The shares were sold at an average price of $221.75, for a total value of $5,011,106.50. Following the completion of the sale, the chief executive officer now owns 195,314 shares in the company, valued at approximately $43,310,879.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Kenneth Irwin Shine sold 198 shares of the firm’s stock in a transaction dated Friday, January 19th. The shares were sold at an average price of $242.55, for a total transaction of $48,024.90. Following the completion of the sale, the director now owns 1,790,567 shares of the company’s stock, valued at approximately $434,302,025.85. The disclosure for this sale can be found here. Insiders have sold a total of 53,196 shares of company stock valued at $12,291,179 over the last three months. 0.89% of the stock is currently owned by insiders.
UnitedHealth Group Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).